No Data
IN8bio Advances Cancer Therapies Amid Financial Restructuring
TipRanksNov 13 23:43 ET
IN8bio Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 13 09:05 ET · Ratings
IN8bio Analyst Ratings
BenzingaNov 13 08:53 ET · Ratings
Express News | IN8bio, Inc. : H.c. Wainwright Cuts Target Price to $8 From $12.5
ReutersNov 13 06:07 ET
In8bio | 10-Q: Q3 2024 Earnings Report
SECNov 12 16:40 ET · Announcements
Express News | IN8bio Q3 Basic EPS USD -0.15
ReutersNov 12 16:26 ET
10baggerbamm : it's probably just getting started most of this stuff runs for a few days if you got the brass ones to stay in them
10baggerbamm : I just tossed in an order
Salmon Klein OP 10baggerbamm : well done!! I definitely sold too early. this one has chances to get to 1
10baggerbamm Salmon Klein OP : or fall back down to 10 cents
Salmon Klein OP 10baggerbamm : hahahaha true...normally high then to back to hell hehehe...this one no too bad financials
View more comments...